QQQ $ 434.24 $ 1.84 (0.43 %)
DIA $ 387.87 $ 1.13 (0.29 %)
SPY $ 511.26 $ 0.73 (0.14 %)
TLT $ 89.96 $ -0.15 (-0.17 %)
GLD $ 212.88 $ -0.54 (-0.25 %)
$ 0.28
-- x --
-- x --
-- - --
$ 0.12 - $ 1.28
62,385
na
25.34M
$ 0.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-caribou-biosciences-shares-are-trading-higher-by-around-58-here-are-other-stocks-moving-in-thursdays-session

Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equ...

 why-vbi-vaccines-are-trading-lower-by-over-23-here-are-20-stocks-moving-premarket

Gainers Akumin Inc. (NASDAQ: AKU) shares surged 58.2% to $0.2865 in pre-market trading. Akumin recently named Krishna Kumar ...

 nymox-pharmaceutical-says-terminated-employment-of-each-of-cfo-christopher-riley-and-coo-randall-lanham

The Company has initiated a search for a Chief Financial Officer, and is in the process of hiring a general counsel to assume t...

 nymox-provides-current-update
Nymox Provides Current Update
05/10/2023 14:00:55

 Nymox Pharmaceutical Corporation (NASDAQ:NYMX) (the "Company") is pleased to provide a mid-2nd quarter update on ongoi...

 nymox-announces-appointment-of-christopher-r-riley-as-chief-financial-officer

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) (the "Company") is pleased to announce the appointment of Christopher R....

 nymox-officially-granted-extension-until-july-3-2023-to-regain-listing-requirements

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) (the "Company") has officially been granted by NASDAQ an additional peri...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION